IBDEI0I1 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8427,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8427,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,8427,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,8427,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,8428,0)
 ;;=287.0^^35^484^64
 ;;^UTILITY(U,$J,358.3,8428,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8428,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,8428,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,8428,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,8429,0)
 ;;=782.1^^35^484^65
 ;;^UTILITY(U,$J,358.3,8429,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8429,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,8429,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,8429,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,8430,0)
 ;;=706.2^^35^484^69
 ;;^UTILITY(U,$J,358.3,8430,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8430,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,8430,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,8430,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,8431,0)
 ;;=690.10^^35^484^72
 ;;^UTILITY(U,$J,358.3,8431,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8431,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,8431,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,8431,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,8432,0)
 ;;=702.11^^35^484^70
 ;;^UTILITY(U,$J,358.3,8432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8432,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,8432,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,8432,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,8433,0)
 ;;=702.19^^35^484^71
 ;;^UTILITY(U,$J,358.3,8433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8433,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,8433,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,8433,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,8434,0)
 ;;=686.9^^35^484^73
 ;;^UTILITY(U,$J,358.3,8434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8434,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,8434,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,8434,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,8435,0)
 ;;=708.9^^35^484^86
 ;;^UTILITY(U,$J,358.3,8435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8435,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,8435,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,8435,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,8436,0)
 ;;=078.10^^35^484^87
 ;;^UTILITY(U,$J,358.3,8436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8436,1,4,0)
 ;;=4^078.10
 ;;^UTILITY(U,$J,358.3,8436,1,5,0)
 ;;=5^Warts
 ;;^UTILITY(U,$J,358.3,8436,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,8437,0)
 ;;=706.8^^35^484^88
 ;;^UTILITY(U,$J,358.3,8437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8437,1,4,0)
 ;;=4^706.8
 ;;^UTILITY(U,$J,358.3,8437,1,5,0)
 ;;=5^Xerosis
 ;;^UTILITY(U,$J,358.3,8437,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,8438,0)
 ;;=710.1^^35^484^68
 ;;^UTILITY(U,$J,358.3,8438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8438,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,8438,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,8438,2)
 ;;=Scleroderma^108590
 ;;^UTILITY(U,$J,358.3,8439,0)
 ;;=707.21^^35^484^54
 ;;^UTILITY(U,$J,358.3,8439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8439,1,4,0)
 ;;=4^707.21
 ;;^UTILITY(U,$J,358.3,8439,1,5,0)
 ;;=5^Pressure Ulcer,Stage I
 ;;^UTILITY(U,$J,358.3,8439,2)
 ;;=^336649
 ;;^UTILITY(U,$J,358.3,8440,0)
 ;;=707.22^^35^484^55
 ;;^UTILITY(U,$J,358.3,8440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8440,1,4,0)
 ;;=4^707.22
 ;;^UTILITY(U,$J,358.3,8440,1,5,0)
 ;;=5^Pressure Ulcer,Stage II
 ;;^UTILITY(U,$J,358.3,8440,2)
 ;;=^336650
 ;;^UTILITY(U,$J,358.3,8441,0)
 ;;=707.23^^35^484^56
 ;;^UTILITY(U,$J,358.3,8441,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0I1
